Pharmafile Logo
Pharmafocus logo
Advanced Search

Ondibta

Showing 1 posts of 1 posts found.

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026
Research and Development Diabetes, Ondibta, Sandoz

Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …

News
The Gateway to Local Adoption Series

Latest content

Care Quality Commission appoints Emily Miles as Chief Executive

July 17, 2026

National survey aims to improve glaucoma care across the UK

July 16, 2026

Phase 3 trials support expanded use of Dysport for migraine prevention

July 15, 2026

Roche secures CE Mark for automated latent tuberculosis blood test

July 14, 2026

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026